ChromaDex (CDXC) PT Raised 90% to $17 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Brian Nagel raised the price target on ChromaDex (NASDAQ: CDXC) to $17.00 (from $9.00) after the company announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE